Click for best price
Umbilical Cord Blood UCB Stem Cell Market Size, Share 2023
Umbilical cord blood stem cells are potential stem cells that can convert into any type of -determined cells.
This report aims to provide a comprehensive presentation of the global market for Umbilical Cord Blood (UCB) Stem Cell, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Umbilical Cord Blood (UCB) Stem Cell. This report contains market size and forecasts of Umbilical Cord Blood (UCB) Stem Cell in global, including the following market information:
Global Umbilical Cord Blood (UCB) Stem Cell Market Revenue, 2018-2023, 2024-2030, ($ millions)
Global top five companies in 2022 (%)
The global Umbilical Cord Blood (UCB) Stem Cell market was valued at US$ million in 2022 and is projected to reach US$ million by 2030, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The U.S. Market is Estimated at $ Million in 2022, While China is to reach $ Million.
Stem Cell Transplant Segment to Reach $ Million by 2030, with a % CAGR in next six years.
The global key manufacturers of Umbilical Cord Blood (UCB) Stem Cell include Advanced Cell Technology, Athersys, California Stem Cell, Cytori Therapeutics, Mesoblast, Opexa Therapeutics and Caladrius Biosciences, etc. in 2022, the global top five players have a share approximately % in terms of revenue.
We surveyed the Umbilical Cord Blood (UCB) Stem Cell companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Umbilical Cord Blood (UCB) Stem Cell Market, by Type, 2018-2023, 2024-2030 ($ millions)
Global Umbilical Cord Blood (UCB) Stem Cell Market Segment Percentages, by Type, 2022 (%)
Stem Cell Transplant
Autologous Transplant
Allogenic Transplant
Transplant Medicine
Regenerative Medicine
Others
Global Umbilical Cord Blood (UCB) Stem Cell Market, by Application, 2018-2023, 2024-2030 ($ millions)
Global Umbilical Cord Blood (UCB) Stem Cell Market Segment Percentages, by Application, 2022 (%)
Therapeutics Service Companies
Private And Government Research Institutes
Academic Institutes
Research Based Pharmaceutical Companies
Public And Private Cord Blood Banks
Others
Global Umbilical Cord Blood (UCB) Stem Cell Market, By Region and Country, 2018-2023, 2024-2030 ($ Millions)
Global Umbilical Cord Blood (UCB) Stem Cell Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Umbilical Cord Blood (UCB) Stem Cell revenues in global market, 2018-2023 (estimated), ($ millions)
Key companies Umbilical Cord Blood (UCB) Stem Cell revenues share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
Advanced Cell Technology
Athersys
California Stem Cell
Cytori Therapeutics
Mesoblast
Opexa Therapeutics
Caladrius Biosciences
Outline of Major Chapters:
Chapter 1: Introduces the definition of Umbilical Cord Blood (UCB) Stem Cell, market overview.
Chapter 2: Global Umbilical Cord Blood (UCB) Stem Cell market size in revenue.
Chapter 3: Detailed analysis of Umbilical Cord Blood (UCB) Stem Cell company competitive landscape, revenue and market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Umbilical Cord Blood (UCB) Stem Cell in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: The main points and conclusions of the report.
| Report Attributes |
Report Details |
| Report Title |
Umbilical Cord Blood (UCB) Stem Cell Market, Global Outlook and Forecast 2023-2030 |
| Historical Year |
2018 to 2022 (Data from 2010 can be provided as per availability) |
| Base Year |
2022 |
| Forecast Year |
2030 |
| Number of Pages |
67 Pages |
| Customization Available |
Yes, the report can be customized as per your need. |
TABLE OF CONTENTS
1 Introduction to Research & Analysis Reports
1.1 Umbilical Cord Blood (UCB) Stem Cell Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Umbilical Cord Blood (UCB) Stem Cell Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Umbilical Cord Blood (UCB) Stem Cell Overall Market Size
2.1 Global Umbilical Cord Blood (UCB) Stem Cell Market Size: 2022 VS 2030
2.2 Global Umbilical Cord Blood (UCB) Stem Cell Market Size, Prospects & Forecasts: 2018-2030
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Umbilical Cord Blood (UCB) Stem Cell Players in Global Market
3.2 Top Global Umbilical Cord Blood (UCB) Stem Cell Companies Ranked by Revenue
3.3 Global Umbilical Cord Blood (UCB) Stem Cell Revenue by Companies
3.4 Top 3 and Top 5 Umbilical Cord Blood (UCB) Stem Cell Companies in Global Market, by Revenue in 2022
3.5 Global Companies Umbilical Cord Blood (UCB) Stem Cell Product Type
3.6 Tier 1, Tier 2 and Tier 3 Umbilical Cord Blood (UCB) Stem Cell Players in Global Market
3.6.1 List of Global Tier 1 Umbilical Cord Blood (UCB) Stem Cell Companies
3.6.2 List of Global Tier 2 and Tier 3 Umbilical Cord Blood (UCB) Stem Cell Companies
4 Market Sights by Product
4.1 Overview
4.1.1 By Type - Global Umbilical Cord Blood (UCB) Stem Cell Market Size Markets, 2022 & 2030
4.1.2 Stem Cell Transplant
4.1.3 Autologous Transplant
4.1.4 Allogenic Transplant
4.1.5 Transplant Medicine
4.1.6 Regenerative Medicine
4.1.7 Others
4.2 By Type - Global Umbilical Cord Blood (UCB) Stem Cell Revenue & Forecasts
4.2.1 By Type - Global Umbilical Cord Blood (UCB) Stem Cell Revenue, 2018-2023
4.2.2 By Type - Global Umbilical Cord Blood (UCB) Stem Cell Revenue, 2024-2030
4.2.3 By Type - Global Umbilical Cord Blood (UCB) Stem Cell Revenue Market Share, 2018-2030
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Umbilical Cord Blood (UCB) Stem Cell Market Size, 2022 & 2030
5.1.2 Therapeutics Service Companies
5.1.3 Private And Government Research Institutes
5.1.4 Academic Institutes
5.1.5 Research Based Pharmaceutical Companies
5.1.6 Public And Private Cord Blood Banks
5.1.7 Others
5.2 By Application - Global Umbilical Cord Blood (UCB) Stem Cell Revenue & Forecasts
5.2.1 By Application - Global Umbilical Cord Blood (UCB) Stem Cell Revenue, 2018-2023
5.2.2 By Application - Global Umbilical Cord Blood (UCB) Stem Cell Revenue, 2024-2030
5.2.3 By Application - Global Umbilical Cord Blood (UCB) Stem Cell Revenue Market Share, 2018-2030
6 Sights by Region
6.1 By Region - Global Umbilical Cord Blood (UCB) Stem Cell Market Size, 2022 & 2030
6.2 By Region - Global Umbilical Cord Blood (UCB) Stem Cell Revenue & Forecasts
6.2.1 By Region - Global Umbilical Cord Blood (UCB) Stem Cell Revenue, 2018-2023
6.2.2 By Region - Global Umbilical Cord Blood (UCB) Stem Cell Revenue, 2024-2030
6.2.3 By Region - Global Umbilical Cord Blood (UCB) Stem Cell Revenue Market Share, 2018-2030
6.3 North America
6.3.1 By Country - North America Umbilical Cord Blood (UCB) Stem Cell Revenue, 2018-2030
6.3.2 US Umbilical Cord Blood (UCB) Stem Cell Market Size, 2018-2030
6.3.3 Canada Umbilical Cord Blood (UCB) Stem Cell Market Size, 2018-2030
6.3.4 Mexico Umbilical Cord Blood (UCB) Stem Cell Market Size, 2018-2030
6.4 Europe
6.4.1 By Country - Europe Umbilical Cord Blood (UCB) Stem Cell Revenue, 2018-2030
6.4.2 Germany Umbilical Cord Blood (UCB) Stem Cell Market Size, 2018-2030
6.4.3 France Umbilical Cord Blood (UCB) Stem Cell Market Size, 2018-2030
6.4.4 U.K. Umbilical Cord Blood (UCB) Stem Cell Market Size, 2018-2030
6.4.5 Italy Umbilical Cord Blood (UCB) Stem Cell Market Size, 2018-2030
6.4.6 Russia Umbilical Cord Blood (UCB) Stem Cell Market Size, 2018-2030
6.4.7 Nordic Countries Umbilical Cord Blood (UCB) Stem Cell Market Size, 2018-2030
6.4.8 Benelux Umbilical Cord Blood (UCB) Stem Cell Market Size, 2018-2030
6.5 Asia
6.5.1 By Region - Asia Umbilical Cord Blood (UCB) Stem Cell Revenue, 2018-2030
6.5.2 China Umbilical Cord Blood (UCB) Stem Cell Market Size, 2018-2030
6.5.3 Japan Umbilical Cord Blood (UCB) Stem Cell Market Size, 2018-2030
6.5.4 South Korea Umbilical Cord Blood (UCB) Stem Cell Market Size, 2018-2030
6.5.5 Southeast Asia Umbilical Cord Blood (UCB) Stem Cell Market Size, 2018-2030
6.5.6 India Umbilical Cord Blood (UCB) Stem Cell Market Size, 2018-2030
6.6 South America
6.6.1 By Country - South America Umbilical Cord Blood (UCB) Stem Cell Revenue, 2018-2030
6.6.2 Brazil Umbilical Cord Blood (UCB) Stem Cell Market Size, 2018-2030
6.6.3 Argentina Umbilical Cord Blood (UCB) Stem Cell Market Size, 2018-2030
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Umbilical Cord Blood (UCB) Stem Cell Revenue, 2018-2030
6.7.2 Turkey Umbilical Cord Blood (UCB) Stem Cell Market Size, 2018-2030
6.7.3 Israel Umbilical Cord Blood (UCB) Stem Cell Market Size, 2018-2030
6.7.4 Saudi Arabia Umbilical Cord Blood (UCB) Stem Cell Market Size, 2018-2030
6.7.5 UAE Umbilical Cord Blood (UCB) Stem Cell Market Size, 2018-2030
7 Umbilical Cord Blood (UCB) Stem Cell Companies Profiles
7.1 Advanced Cell Technology
7.1.1 Advanced Cell Technology Company Summary
7.1.2 Advanced Cell Technology Business Overview
7.1.3 Advanced Cell Technology Umbilical Cord Blood (UCB) Stem Cell Major Product Offerings
7.1.4 Advanced Cell Technology Umbilical Cord Blood (UCB) Stem Cell Revenue in Global Market (2018-2023)
7.1.5 Advanced Cell Technology Key News & Latest Developments
7.2 Athersys
7.2.1 Athersys Company Summary
7.2.2 Athersys Business Overview
7.2.3 Athersys Umbilical Cord Blood (UCB) Stem Cell Major Product Offerings
7.2.4 Athersys Umbilical Cord Blood (UCB) Stem Cell Revenue in Global Market (2018-2023)
7.2.5 Athersys Key News & Latest Developments
7.3 California Stem Cell
7.3.1 California Stem Cell Company Summary
7.3.2 California Stem Cell Business Overview
7.3.3 California Stem Cell Umbilical Cord Blood (UCB) Stem Cell Major Product Offerings
7.3.4 California Stem Cell Umbilical Cord Blood (UCB) Stem Cell Revenue in Global Market (2018-2023)
7.3.5 California Stem Cell Key News & Latest Developments
7.4 Cytori Therapeutics
7.4.1 Cytori Therapeutics Company Summary
7.4.2 Cytori Therapeutics Business Overview
7.4.3 Cytori Therapeutics Umbilical Cord Blood (UCB) Stem Cell Major Product Offerings
7.4.4 Cytori Therapeutics Umbilical Cord Blood (UCB) Stem Cell Revenue in Global Market (2018-2023)
7.4.5 Cytori Therapeutics Key News & Latest Developments
7.5 Mesoblast
7.5.1 Mesoblast Company Summary
7.5.2 Mesoblast Business Overview
7.5.3 Mesoblast Umbilical Cord Blood (UCB) Stem Cell Major Product Offerings
7.5.4 Mesoblast Umbilical Cord Blood (UCB) Stem Cell Revenue in Global Market (2018-2023)
7.5.5 Mesoblast Key News & Latest Developments
7.6 Opexa Therapeutics
7.6.1 Opexa Therapeutics Company Summary
7.6.2 Opexa Therapeutics Business Overview
7.6.3 Opexa Therapeutics Umbilical Cord Blood (UCB) Stem Cell Major Product Offerings
7.6.4 Opexa Therapeutics Umbilical Cord Blood (UCB) Stem Cell Revenue in Global Market (2018-2023)
7.6.5 Opexa Therapeutics Key News & Latest Developments
7.7 Caladrius Biosciences
7.7.1 Caladrius Biosciences Company Summary
7.7.2 Caladrius Biosciences Business Overview
7.7.3 Caladrius Biosciences Umbilical Cord Blood (UCB) Stem Cell Major Product Offerings
7.7.4 Caladrius Biosciences Umbilical Cord Blood (UCB) Stem Cell Revenue in Global Market (2018-2023)
7.7.5 Caladrius Biosciences Key News & Latest Developments
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
LIST OF TABLES & FIGURES
List of Tables
Table 1. Umbilical Cord Blood (UCB) Stem Cell Market Opportunities & Trends in Global Market
Table 2. Umbilical Cord Blood (UCB) Stem Cell Market Drivers in Global Market
Table 3. Umbilical Cord Blood (UCB) Stem Cell Market Restraints in Global Market
Table 4. Key Players of Umbilical Cord Blood (UCB) Stem Cell in Global Market
Table 5. Top Umbilical Cord Blood (UCB) Stem Cell Players in Global Market, Ranking by Revenue (2022)
Table 6. Global Umbilical Cord Blood (UCB) Stem Cell Revenue by Companies, (US$, Mn), 2018-2023
Table 7. Global Umbilical Cord Blood (UCB) Stem Cell Revenue Share by Companies, 2018-2023
Table 8. Global Companies Umbilical Cord Blood (UCB) Stem Cell Product Type
Table 9. List of Global Tier 1 Umbilical Cord Blood (UCB) Stem Cell Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Umbilical Cord Blood (UCB) Stem Cell Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 11. By Type ? Global Umbilical Cord Blood (UCB) Stem Cell Revenue, (US$, Mn), 2022 & 2030
Table 12. By Type - Umbilical Cord Blood (UCB) Stem Cell Revenue in Global (US$, Mn), 2018-2023
Table 13. By Type - Umbilical Cord Blood (UCB) Stem Cell Revenue in Global (US$, Mn), 2024-2030
Table 14. By Application ? Global Umbilical Cord Blood (UCB) Stem Cell Revenue, (US$, Mn), 2022 & 2030
Table 15. By Application - Umbilical Cord Blood (UCB) Stem Cell Revenue in Global (US$, Mn), 2018-2023
Table 16. By Application - Umbilical Cord Blood (UCB) Stem Cell Revenue in Global (US$, Mn), 2024-2030
Table 17. By Region ? Global Umbilical Cord Blood (UCB) Stem Cell Revenue, (US$, Mn), 2022 & 2030
Table 18. By Region - Global Umbilical Cord Blood (UCB) Stem Cell Revenue (US$, Mn), 2018-2023
Table 19. By Region - Global Umbilical Cord Blood (UCB) Stem Cell Revenue (US$, Mn), 2024-2030
Table 20. By Country - North America Umbilical Cord Blood (UCB) Stem Cell Revenue, (US$, Mn), 2018-2023
Table 21. By Country - North America Umbilical Cord Blood (UCB) Stem Cell Revenue, (US$, Mn), 2024-2030
Table 22. By Country - Europe Umbilical Cord Blood (UCB) Stem Cell Revenue, (US$, Mn), 2018-2023
Table 23. By Country - Europe Umbilical Cord Blood (UCB) Stem Cell Revenue, (US$, Mn), 2024-2030
Table 24. By Region - Asia Umbilical Cord Blood (UCB) Stem Cell Revenue, (US$, Mn), 2018-2023
Table 25. By Region - Asia Umbilical Cord Blood (UCB) Stem Cell Revenue, (US$, Mn), 2024-2030
Table 26. By Country - South America Umbilical Cord Blood (UCB) Stem Cell Revenue, (US$, Mn), 2018-2023
Table 27. By Country - South America Umbilical Cord Blood (UCB) Stem Cell Revenue, (US$, Mn), 2024-2030
Table 28. By Country - Middle East & Africa Umbilical Cord Blood (UCB) Stem Cell Revenue, (US$, Mn), 2018-2023
Table 29. By Country - Middle East & Africa Umbilical Cord Blood (UCB) Stem Cell Revenue, (US$, Mn), 2024-2030
Table 30. Advanced Cell Technology Company Summary
Table 31. Advanced Cell Technology Umbilical Cord Blood (UCB) Stem Cell Product Offerings
Table 32. Advanced Cell Technology Umbilical Cord Blood (UCB) Stem Cell Revenue (US$, Mn) & (2018-2023)
Table 33. Advanced Cell Technology Key News & Latest Developments
Table 34. Athersys Company Summary
Table 35. Athersys Umbilical Cord Blood (UCB) Stem Cell Product Offerings
Table 36. Athersys Umbilical Cord Blood (UCB) Stem Cell Revenue (US$, Mn) & (2018-2023)
Table 37. Athersys Key News & Latest Developments
Table 38. California Stem Cell Company Summary
Table 39. California Stem Cell Umbilical Cord Blood (UCB) Stem Cell Product Offerings
Table 40. California Stem Cell Umbilical Cord Blood (UCB) Stem Cell Revenue (US$, Mn) & (2018-2023)
Table 41. California Stem Cell Key News & Latest Developments
Table 42. Cytori Therapeutics Company Summary
Table 43. Cytori Therapeutics Umbilical Cord Blood (UCB) Stem Cell Product Offerings
Table 44. Cytori Therapeutics Umbilical Cord Blood (UCB) Stem Cell Revenue (US$, Mn) & (2018-2023)
Table 45. Cytori Therapeutics Key News & Latest Developments
Table 46. Mesoblast Company Summary
Table 47. Mesoblast Umbilical Cord Blood (UCB) Stem Cell Product Offerings
Table 48. Mesoblast Umbilical Cord Blood (UCB) Stem Cell Revenue (US$, Mn) & (2018-2023)
Table 49. Mesoblast Key News & Latest Developments
Table 50. Opexa Therapeutics Company Summary
Table 51. Opexa Therapeutics Umbilical Cord Blood (UCB) Stem Cell Product Offerings
Table 52. Opexa Therapeutics Umbilical Cord Blood (UCB) Stem Cell Revenue (US$, Mn) & (2018-2023)
Table 53. Opexa Therapeutics Key News & Latest Developments
Table 54. Caladrius Biosciences Company Summary
Table 55. Caladrius Biosciences Umbilical Cord Blood (UCB) Stem Cell Product Offerings
Table 56. Caladrius Biosciences Umbilical Cord Blood (UCB) Stem Cell Revenue (US$, Mn) & (2018-2023)
Table 57. Caladrius Biosciences Key News & Latest Developments
List of Figures
Figure 1. Umbilical Cord Blood (UCB) Stem Cell Segment by Type in 2022
Figure 2. Umbilical Cord Blood (UCB) Stem Cell Segment by Application in 2022
Figure 3. Global Umbilical Cord Blood (UCB) Stem Cell Market Overview: 2022
Figure 4. Key Caveats
Figure 5. Global Umbilical Cord Blood (UCB) Stem Cell Market Size: 2022 VS 2030 (US$, Mn)
Figure 6. Global Umbilical Cord Blood (UCB) Stem Cell Revenue, 2018-2030 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Umbilical Cord Blood (UCB) Stem Cell Revenue in 2022
Figure 8. By Type - Global Umbilical Cord Blood (UCB) Stem Cell Revenue Market Share, 2018-2030
Figure 9. By Application - Global Umbilical Cord Blood (UCB) Stem Cell Revenue Market Share, 2018-2030
Figure 10. By Type - Global Umbilical Cord Blood (UCB) Stem Cell Revenue, (US$, Mn), 2022 & 2030
Figure 11. By Type - Global Umbilical Cord Blood (UCB) Stem Cell Revenue Market Share, 2018-2030
Figure 12. By Application - Global Umbilical Cord Blood (UCB) Stem Cell Revenue, (US$, Mn), 2022 & 2030
Figure 13. By Application - Global Umbilical Cord Blood (UCB) Stem Cell Revenue Market Share, 2018-2030
Figure 14. By Region - Global Umbilical Cord Blood (UCB) Stem Cell Revenue Market Share, 2018-2030
Figure 15. By Country - North America Umbilical Cord Blood (UCB) Stem Cell Revenue Market Share, 2018-2030
Figure 16. US Umbilical Cord Blood (UCB) Stem Cell Revenue, (US$, Mn), 2018-2030
Figure 17. Canada Umbilical Cord Blood (UCB) Stem Cell Revenue, (US$, Mn), 2018-2030
Figure 18. Mexico Umbilical Cord Blood (UCB) Stem Cell Revenue, (US$, Mn), 2018-2030
Figure 19. By Country - Europe Umbilical Cord Blood (UCB) Stem Cell Revenue Market Share, 2018-2030
Figure 20. Germany Umbilical Cord Blood (UCB) Stem Cell Revenue, (US$, Mn), 2018-2030
Figure 21. France Umbilical Cord Blood (UCB) Stem Cell Revenue, (US$, Mn), 2018-2030
Figure 22. U.K. Umbilical Cord Blood (UCB) Stem Cell Revenue, (US$, Mn), 2018-2030
Figure 23. Italy Umbilical Cord Blood (UCB) Stem Cell Revenue, (US$, Mn), 2018-2030
Figure 24. Russia Umbilical Cord Blood (UCB) Stem Cell Revenue, (US$, Mn), 2018-2030
Figure 25. Nordic Countries Umbilical Cord Blood (UCB) Stem Cell Revenue, (US$, Mn), 2018-2030
Figure 26. Benelux Umbilical Cord Blood (UCB) Stem Cell Revenue, (US$, Mn), 2018-2030
Figure 27. By Region - Asia Umbilical Cord Blood (UCB) Stem Cell Revenue Market Share, 2018-2030
Figure 28. China Umbilical Cord Blood (UCB) Stem Cell Revenue, (US$, Mn), 2018-2030
Figure 29. Japan Umbilical Cord Blood (UCB) Stem Cell Revenue, (US$, Mn), 2018-2030
Figure 30. South Korea Umbilical Cord Blood (UCB) Stem Cell Revenue, (US$, Mn), 2018-2030
Figure 31. Southeast Asia Umbilical Cord Blood (UCB) Stem Cell Revenue, (US$, Mn), 2018-2030
Figure 32. India Umbilical Cord Blood (UCB) Stem Cell Revenue, (US$, Mn), 2018-2030
Figure 33. By Country - South America Umbilical Cord Blood (UCB) Stem Cell Revenue Market Share, 2018-2030
Figure 34. Brazil Umbilical Cord Blood (UCB) Stem Cell Revenue, (US$, Mn), 2018-2030
Figure 35. Argentina Umbilical Cord Blood (UCB) Stem Cell Revenue, (US$, Mn), 2018-2030
Figure 36. By Country - Middle East & Africa Umbilical Cord Blood (UCB) Stem Cell Revenue Market Share, 2018-2030
Figure 37. Turkey Umbilical Cord Blood (UCB) Stem Cell Revenue, (US$, Mn), 2018-2030
Figure 38. Israel Umbilical Cord Blood (UCB) Stem Cell Revenue, (US$, Mn), 2018-2030
Figure 39. Saudi Arabia Umbilical Cord Blood (UCB) Stem Cell Revenue, (US$, Mn), 2018-2030
Figure 40. UAE Umbilical Cord Blood (UCB) Stem Cell Revenue, (US$, Mn), 2018-2030
Figure 41. Advanced Cell Technology Umbilical Cord Blood (UCB) Stem Cell Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 42. Athersys Umbilical Cord Blood (UCB) Stem Cell Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 43. California Stem Cell Umbilical Cord Blood (UCB) Stem Cell Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 44. Cytori Therapeutics Umbilical Cord Blood (UCB) Stem Cell Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 45. Mesoblast Umbilical Cord Blood (UCB) Stem Cell Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 46. Opexa Therapeutics Umbilical Cord Blood (UCB) Stem Cell Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 47. Caladrius Biosciences Umbilical Cord Blood (UCB) Stem Cell Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
